Death and the retrovirus

Trends in Molecular Medicine

Volumn 9, Issue 10, 2003, Pages 409-413

  Vartanian, Jean Pierre ^a   Sommer, Peter ^a   Wain Hobson, Simon ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

COMPLEX FORMATION; DEATH; DNA SYNTHESIS; GENE MUTATION; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; RETROVIRUS; REVERSE TRANSCRIPTION; REVIEW; VIRION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0142246197     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.08.008     Document Type: Short Survey

References (20)

1. Sheehy, A. et al. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650
2. Lecossier, D. et al. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112
3. Mangeat, B. et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103
4. Harris, R.S. et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809
5. Mariani, R. et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31
6. Zhang, H. et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98
7. Harris, R.S. et al. (2003) DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat. Immunol. 4, 641-643
8. Desrosiers, R. et al. (1999) Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 78, 1431-1437
9. Jarmuz, A. et al. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296
10. Vartanian, J.P. et al. (1991) Selection, recombination and G → A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65, 1779-1788
11. Vartanian, J.P. et al. (2002) Sustained G → A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83, 801-805
12. Mansky, L.M. (2000) In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J. Virol. 74, 9525-9531
13. Vartanian, J.P. et al. (1997) HIV genetic variation is directed and restricted by DNA precursor availability. J. Mol. Biol. 270, 139-151
14. Gunther, S. et al. (1997) Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G → A hypermutation. Virology 235, 104-108
15. Calmus, Y. et al. (1994) Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patients. Eur. J. Clin. Invest. 24, 548-552
16. Chester, A. et al. (2000) RNA editing: cytidine to uridine conversion in apolipoprotein-B mRNA in vitro. Biochim. Biophys. Acta 1494, 1-13
17. Vartanian, J.P. et al. (1994) G → A hypermutation of the HIV-1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc. Natl. Acad. Sci. U. S. A. 91, 3092-3096
18. Martinez, M.A. et al. (1994) Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl. Acad. Sci. U. S. A. 91, 11787-11791
19. Martinez, M.A. et al. (1995) Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucleic Acids Res. 23, 2573-2578
20. Chen, R. et al. (2002) Roles of uracil-DNA glycosylase and dUTPase in virus replication. J. Gen. Virol. 83, 2339-2345